A global development expert with more than 15 years’ experience in public health startups and advocacy movements, Ms. Stoever will provide strategic guidance to the LIBD leadership and manage all aspects of the organization’s external relations and development efforts.
“The creation of the CERO position marks an exciting new phase in the Institute’s growth and progress,” said Daniel R. Weinberger, M.D., Director and Chief Executive Officer of LIBD. “Since its founding in 2010, the Institute has established a strong foundation for advancing scientific understanding of schizophrenia and other developmental brain disorders in order to find new treatments for these conditions. With the contribution of Kari’s expertise, the Institute is poised for a significant expansion of its partnerships and capabilities.”
Before joining LIBD, Ms. Stoever served as Senior Director of Co-Investment at Girl Effect, a global movement to accelerate progress for more than 250 million girls living in poverty, founded by the NIKE Foundation. Working in the office of the CEO, Ms. Stoever supported efforts to resource the launch of Girl Effect as an independent organization in 2015, building up existing and new partnerships to increase the impact of the movement globally.
Previously, Ms. Stoever was Vice President of External Affairs at Aeras, a global nonprofit biotech developing next generation tuberculosis vaccines, where she co-developed the world’s first investment case and blended capital model to support TB vaccine R&D. Prior to Aeras, she was the President and Founder of Meliora Global, LLC, a firm focused on growth strategies for nonprofits and social ventures.
At the Sabin Institute, she helped establish and was the Managing Director of the Global Network for Neglected Tropical Diseases (NTD). She was the Principal Investigator on a $34 million grant by the Bill & Melinda Gates Foundation to establish regional financing mechanisms and to increase international investments for the scale-up of NTD control and elimination strategies globally. Under her leadership, the Global Network secured more than US $100 million in grants and financial commitments and contributed in the development of a US $1 billion, 5-year strategy for NTDs.
Ms. Stoever holds a bachelor’s degree in clinical research from George Washington University, a degree in nursing, and an Executive Masters in Leadership from the McDonough School of Business at Georgetown University.